Dicloxacillin Bluefish Hart hylki 250 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

dicloxacillin bluefish hart hylki 250 mg

bluefish pharmaceuticals ab - dicloxacillinum natríum - hart hylki - 250 mg

Ringer-Acetat Baxter Viaflo Innrennslislyf, lausn Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

ringer-acetat baxter viaflo innrennslislyf, lausn

baxter medical ab* - natrii chloridum; kalii chloridum; calcium chloride; magnesii chloridum; natrii acetas - innrennslislyf, lausn

Noromectin Stungulyf, lausn 1 % w/v Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

noromectin stungulyf, lausn 1 % w/v

norbrook laboratories (ireland) limited - ivermectinum inn - stungulyf, lausn - 1 % w/v

Dicloxacillin Bluefish Hart hylki 500 mg Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

dicloxacillin bluefish hart hylki 500 mg

bluefish pharmaceuticals ab - dicloxacillinum natríum - hart hylki - 500 mg

Plasmalyte Innrennslislyf, lausn Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

plasmalyte innrennslislyf, lausn

baxter medical ab* - sodium chloride; kalii chloridum; magnesii chloridum; sodium acetate trihydrate; natrii gluconas - innrennslislyf, lausn

Advate Unión Europea - islandés - EMA (European Medicines Agency)

advate

takeda manufacturing austria ag - octocog alfa - hemophilia a - antihemorrhagics - meðferð og fyrirbyggjandi blæðingar hjá sjúklingum með dreyrasýki a (meðfæddan þáttur viii-skortur). advate inniheldur ekki von willebrand þáttur í ly árangri magni og er því ekki fram í von willebrand sjúkdómur.

Ceprotin Unión Europea - islandés - EMA (European Medicines Agency)

ceprotin

takeda manufacturing austria ag - manna prótein c - purpura fulminans; protein c deficiency - blóðþurrðandi lyf - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Darunavir Mylan Unión Europea - islandés - EMA (European Medicines Agency)

darunavir mylan

mylan pharmaceuticals limited - darunavir - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - darunavir, co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv-1) infection (see section 4. darunavir mylan 75 mg, 150 mg, 300 mg and 600 mg tablets may be used to provide suitable dose regimens (see section 4. 2):fyrir meðferð hiv-1 sýkingu í andretróveirumeðferð (list)-reynda hjá fullorðnum, þar á meðal þeirra sem hafa verið mjög fyrir fengu. fyrir meðferð hiv-1 sýkingu í börn sjúklingar frá 3 ára og að minnsta kosti 15 kg. Í ákveðið að hefja meðferð með darunavir co-gefið með lítinn skammt rítónavír, vandlega íhugun ætti að meðferð sögu sjúklingur og mynstur stökkbreytingar tengslum með mismunandi lyf. genotypic or phenotypic testing (when available) and treatment history should guide the use of darunavir (see sections 4. 2, 4. 4 og 5. darunavir co-gefið með lítinn skammt rítónavír er ætlað ásamt öðrum antiretroviral lyf til meðferð við sjúklinga með hiv veira (hiv-1) sýkingu.  darunavir co-administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg) (see section 4.  darunavir mylan 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv-1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are: antiretroviral therapy (art)-naïve (see section 4.  art-experienced with no darunavir resistance associated mutations (drv-rams) and who have plasma hiv-1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 10⁶/l. Í ákveðið að hefja meðferð með darunavir í svona list-upplifað sjúklingar, arfgerðar prófa ætti að fylgja því að nota darunavir (sjá kafla 4. 2, 4. 3, 4. 4 og 5.

Cardalis Unión Europea - islandés - EMA (European Medicines Agency)

cardalis

ceva santé animale - benazepril hydrochloride, spironolactone - ÆÐakerfi - hundar - til meðferðar á hjartabilun vegna langvinna hrörnunarsjúkdóma í hundum (með þvagræsilyfjum eftir því sem við á).

Clomicalm Unión Europea - islandés - EMA (European Medicines Agency)

clomicalm

virbac s.a. - clomipramine hydrochloride - sálgreiningarefni - hundar - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.